Medicinal Genomics And Courtagen Announce CannMed 2016, The Personalized Cannabinoid Medicine Conference, April 10-11, 2016

WOBURN, Mass.--(BUSINESS WIRE)--Medicinal Genomics Corporation and Courtagen Life Sciences, Inc. today announced that they will host the inaugural CannMed 2016 Personalized Cannabinoid Medicine Conference to be held on April 10th and 11th in Boston, MA. The conference will be the first to focus on the intersection of clinical application, medical research, and cannabis based therapeutics related to neurological disorders, such as epilepsy, developmental delay, chronic and neuropathic pain, Alzheimer’s, Parkinson’s, traumatic brain injury, as well as other disease areas.